AXIL Brands Inc (AXIL)

[ProfitScout]

Reviv3 Procare Company Appoints Heather Cornell as Director of Investor Relations

LOS ANGELES, California, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reviv3 Procare Company (RVIV) announced today that Ms. Heather Cornell has joined the company as Director of Investor Relations. Ms. Cornell will lead Reviv3’s corporate communication of its strategies, corporate initiatives and roadmap to analysts and investors. Ms. Cornell has over 20 years of experience in communications, strategic marketing and leading presentations at conferences and corporate events.

“Heather brings a strong set of competencies to Reviv3 as we continue to enhance our communication and corporate relationship with the investment community and we are excited to have her join our team,” said Donald Starace, President of Reviv3. “Her addition to Reviv3 allows us to effectively share our company outlook and shareholder value proposition.”

Ms. Cornell commented, “I look forward to contributing my expertise in corporate engagement and communication to Reviv3 during this remarkable period for the company. I will work to proactively anticipate and address investor focus areas and maintain a strong relationship of trust and respect with the investor community.”

About Reviv3 Procare Company

Reviv3 Procare Company is engaged in the manufacturing, marketing, sales, and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in the United States, Canada, Europe, and Asia.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipates,” “expects,” “intends,” “plans,” “confident that” and “believes,” among others, generally identify as forward-looking statements.

These forward-looking statements are based on currently available information, management’s beliefs, future projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3’s ability to grow net sales and adjusted EBITDA as anticipated (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3’s ability to compete effectively with other hair and skin care companies (v) the concentration of Reviv3’s customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3’s product costs and other costs of doing business, and reduce Reviv3’s earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

Heather Cornell
888-638-8883
[e-mail]

Reviv3.com

[StockHighAlert-]

$RVIV News is out! Reviv3 Procare Company Appoints Heather Cornell as Director of Investor Relations https://finance.yahoo.com/news/reviv3-procare-company-appoints-heather-120000671.html

[ProfitScout]

When you have a high quality beauty care product line that delivers superior results as we see from RVIV, the end result is growth of market share and rising revenues. This is the way a success story happens, especially with a high profile retail product line. Lots of upside potential here for the future since the products are clearly what the marketplace wants.

Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.

[jedijazz]

RVIV Nine months ended February 28, 2019 results

Revenues for the nine months periods ended February 28, 2019 and 2018 were $662,401 and $466,408, respectively. Revenues for the nine months period ended February 28, 2019 increased by $195,993 or 42% compared to the same comparable period in 2018.

Cost of sales for the nine months ended February 28, 2019 and 2018 was $382,238 and $247,359, respectively. Cost of sales as a percentage of sales for the nine months ended February 28, 2019 and 2018 was 58% and 53%, respectively.

Operating expenses for the nine months ended February 28, 2019 and 2018 were $434,790 and $557,005, respectively. Operating expenses as a percentage of revenues for the nine months ended February 28, 2019 and 2018 were 66% and 119% respectively. Operating expenses for the nine months ended February 28, 2019 decreased by $122,215 or 22% compared to the comparable period in 2018.

On a GAAP basis, our net loss was $154,910. This compares to a net loss of $340,937 in the first nine months of 2018.

About Reviv3

Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.

Forward-Looking Statements

This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipates,” “expects,” “intends,” “plans,” “confident that” and “believes,” among others, generally identify forward-looking statements.

These forward-looking statements are based on currently available information, and management’s belief, projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3’s ability to grow net sales and adjusted EBITDA as anticipated; (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3’s ability to compete effectively with other hair and skin care companies (v) the concentration of Reviv3’s customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3’s product costs and other costs of doing business, and reduce Reviv3’s earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

Christopher Go
888-638-8883
[e-mail]

[jedijazz]

“We have made meaningful progress towards achieving profitability as we implement efficiencies in our operations while increasing revenues. In the quarter, we reported a 96% decrease in net loss compared to same period last year. Our operating expenses as a percentage of revenues for the three months ended February 28, 2019 was 45% compared to 89% for the same period last year as we continue to implement our cost management measures. We believe these achievements as well as other on-going initiatives create a foundation for our future growth. We will continue to focus on creating value for our shareholders by enhancing our existing processes and exploring strategic alternatives to achieve profitability and increase topline growth.”

Jeff Toghraie, Chairman and CEO of REVIV3 (RVIV)

[jedijazz]

$RVIV Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.

[budfoxfun]

Closing green, could see a gap up tomorrow!

RVIV

[jedijazz]

$RVIV Background. Founded in 2015, Reviv3 launched its primary hair care products in Italy to be sold exclusively in salons.

REVIV3 is trading under the symbol RVIV on the OTCQB.

Reviv3 products were primarily used for:
increased hair strength, improved scalp health, reduced inflammation
and delivery of nutrients for optimum follicle health.
Shortly after launch, the products received highly positive reviews by
clients and industry publications. In late 2015, REVIV3 began expansion
of its Salon Distribution Network to North America and Canada.
Reviv3 domestic and international sales channels are expanding through
new distribution agreements and strategic partnerships.
In late 2018, REVIV3 launched its Direct to Consumer Marketing
initiatives to include:
• Local and National News Editorials
• Influencer Outreach
• Print publications and Editorials
Reviv3’s Professional quality products will be directly marketed to
consumers via a robust eCommerce site currently in development and
Amazon’s exclusive Professional Beauty Platform.

[jedijazz]

RVIV Executive Summary: plus #OTCQB News today as Reviv3 Procare Company Discusses Business Plan and Recent Financial Results

[jedijazz]

$RVIV .78 +8.33% Reviv3 Procare Third Quarter 2019 Financial Results Third Quarter Highlights
*Revenues increased by 28% compared to the same comparable period in 2018.
*Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
*Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018. https://www.globenewswire.com/news-release/2019/04/10/1802373/0/en/Reviv3-Procare-Company-Reports-Third-Quarter-2019-Financial-Results.html

[Robertscott]

Shares being held tight RVIV

[Robertscott]

Nive. RVIV is pretty thin right now

[budfoxfun]

Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia. https://finance.yahoo.com/news/president-reviv3-procare-company-discusses-120000944.html

RVIV

[budfoxfun]

only 3k shares left on the ask!

RVIV

[Robertscott]

$RVIV Trader's Cheat Sheet https://www.barchart.com/stocks/quotes/RVIV/cheat-sheet

[Robertscott]

Ask getting early attention RVIV

[budfoxfun]

Thin to .80's!

RVIV

[budfoxfun]

The interview can be heard at: https://www.smallcapvoice.com/5-3-19-smallcapvoice-interview-with-reviv3-procare-company-rviv/.

$RVIV

[budfoxfun]

Starace called in to SmallCapVoice.com to discuss the Company’s premium line of hair care products made from the highest quality natural ingredients, the management team’s extensive background in the hair care market, the strong financial footing for the company and much more. Recently, the Company posted their Q3 2019 numbers. Highlights include;

Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.

RVIV

[StockHighAlert-]

$RVIV Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.

[budfoxfun]

"These numbers show why we were so excited to be speaking with SmallCapVoice.com. We are extremely optimistic about our future with the foundation we have built over the last couple of years," stated Starace. " Once again, we are thankful for the opportunity to share our story with our followers and the SmallCapVoice.com listening audience.”

RVIV

[budfoxfun]

Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.

RVIV

[budfoxfun]

Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.

RVIV

[Robertscott]

Donald Starace, president of Reviv3 Procare Company (OTCQB: RVIV), called in to SmallCapVoice.com to discuss the Company’s premium line of hair care products made from the highest quality natural ingredients, the management team’ extensive background in the hair care market, the strong financial footing for the company and much more. Recently, the Company posted their Q3 2019 numbers. Highlights include;

Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018. RVIV

[smallcapvoice]

SmallCapVoice Interview with Reviv3 Procare Company (RVIV)
President of Reviv3 Procare Company Discusses Business Plan and Recent Financial Results in New Interview at SmallCapVoice.com

[Robertscott]

Rising profits and revenue. RVIV doing it right

[Robertscott]

Awesome stuff here on RVIV

[ProfitScout]

I love small cap growth companies like RVIV where management makes the effort to bring their story out in detail. The new interview presentation we have today with at SmallCapVoice.com is a great example of how to do this right.

And RVIV certainly has a good story to tell:

Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.

[budfoxfun]

Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.

RVIV

[budfoxfun]

News Out! $RVIV President of Reviv3 Procare Company Discusses Business Plan and Recent Financial Results in New Interview at SmallCapVoice.com https://finance.yahoo.com/news/president-reviv3-procare-company-discusses-120000944.html

[jedijazz]

$RVIV News as President of Reviv3 Procare Company Discusses Business Plan and Recent Financial Results in New Interview at SmallCapVoice.com
AUSTIN, Texas, May 07, 2019 (GLOBE NEWSWIRE)
The interview can be heard at: https://www.smallcapvoice.com/5-3-19-smallcapvoice-interview-with-reviv3-procare-company-rviv/

[StockHighAlert-]

$RVIV , today announce that Company president Donald Starace is featured in a new audio interview at SmallCapVoice.com.

The interview can be heard at: https://www.smallcapvoice.com/5-3-19-smallcapvoice-interview-with-reviv3-procare-company-rviv/

[jedijazz]

RVIV Nine months ended February 28, 2019 results

Revenues for the nine months periods ended February 28, 2019 and 2018 were $662,401 and $466,408, respectively. Revenues for the nine months period ended February 28, 2019 increased by $195,993 or 42% compared to the same comparable period in 2018.

Cost of sales for the nine months ended February 28, 2019 and 2018 was $382,238 and $247,359, respectively. Cost of sales as a percentage of sales for the nine months ended February 28, 2019 and 2018 was 58% and 53%, respectively.

Operating expenses for the nine months ended February 28, 2019 and 2018 were $434,790 and $557,005, respectively. Operating expenses as a percentage of revenues for the nine months ended February 28, 2019 and 2018 were 66% and 119% respectively. Operating expenses for the nine months ended February 28, 2019 decreased by $122,215 or 22% compared to the comparable period in 2018.

On a GAAP basis, our net loss was $154,910. This compares to a net loss of $340,937 in the first nine months of 2018.

[jedijazz]

$RVIV Reviv3 Procare Company Reports Third Quarter 2019 Financial Results

April 10, 2019 19:03 ET | Source: REVIV3 PROCARE COMPANY
Third Quarter Highlights

Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.
Los Angeles, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reviv3 Procare Company (OTCQB: RVIV) today reported third quarter 2019 financial results. Jeff Toghraie, Chairman and CEO of REVIV3, said, “We have made meaningful progress towards achieving profitability as we implement efficiencies in our operations while increasing revenues. In the quarter, we reported a 96% decrease in net loss compared to same period last year. Our operating expenses as a percentage of revenues for the three months ended February 28, 2019 was 45% compared to 89% for the same period last year as we continue to implement our cost management measures. We believe these achievements as well as other on-going initiatives create a foundation for our future growth. We will continue to focus on creating value for our shareholders by enhancing our existing processes and exploring strategic alternatives to achieve profitability and increase topline growth.”

Nine months ended February 28, 2019 results

Revenues for the nine months periods ended February 28, 2019 and 2018 were $662,401 and $466,408, respectively. Revenues for the nine months period ended February 28, 2019 increased by $195,993 or 42% compared to the same comparable period in 2018.

Cost of sales for the nine months ended February 28, 2019 and 2018 was $382,238 and $247,359, respectively. Cost of sales as a percentage of sales for the nine months ended February 28, 2019 and 2018 was 58% and 53%, respectively.

Operating expenses for the nine months ended February 28, 2019 and 2018 were $434,790 and $557,005, respectively. Operating expenses as a percentage of revenues for the nine months ended February 28, 2019 and 2018 were 66% and 119% respectively. Operating expenses for the nine months ended February 28, 2019 decreased by $122,215 or 22% compared to the comparable period in 2018.

On a GAAP basis, our net loss was $154,910. This compares to a net loss of $340,937 in the first nine months of 2018.

About Reviv3

Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.

Forward-Looking Statements

This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipates,” “expects,” “intends,” “plans,” “confident that” and “believes,” among others, generally identify forward-looking statements.

These forward-looking statements are based on currently available information, and management’s belief, projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3’s ability to grow net sales and adjusted EBITDA as anticipated; (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3’s ability to compete effectively with other hair and skin care companies (v) the concentration of Reviv3’s customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3’s product costs and other costs of doing business, and reduce Reviv3’s earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

Christopher Go
888-638-8883
[e-mail]

[ProfitScout]

Reviv3 Procare Company Reports Third Quarter 2019 Financial Results

Third Quarter Highlights
Revenues increased by 28% compared to the same comparable period in 2018.
Gross profit as a percentage of revenues increased to 43% compared to 38% for the same period in 2018.
Operating Expenses for the 3 months decreased by 36% to the same comparable period in 2018.

Los Angeles, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reviv3 Procare Company (OTCQB: RVIV) today reported third quarter 2019 financial results. Jeff Toghraie, Chairman and CEO of REVIV3, said, “We have made meaningful progress towards achieving profitability as we implement efficiencies in our operations while increasing revenues. In the quarter, we reported a 96% decrease in net loss compared to same period last year. Our operating expenses as a percentage of revenues for the three months ended February 28, 2019 was 45% compared to 89% for the same period last year as we continue to implement our cost management measures. We believe these achievements as well as other on-going initiatives create a foundation for our future growth. We will continue to focus on creating value for our shareholders by enhancing our existing processes and exploring strategic alternatives to achieve profitability and increase topline growth.”Nine months ended February 28, 2019 results

Revenues for the nine months periods ended February 28, 2019 and 2018 were $662,401 and $466,408, respectively. Revenues for the nine months period ended February 28, 2019 increased by $195,993 or 42% compared to the same comparable period in 2018.Cost of sales for the nine months ended February 28, 2019 and 2018 was $382,238 and $247,359, respectively. Cost of sales as a percentage of sales for the nine months ended February 28, 2019 and 2018 was 58% and 53%, respectively.Operating expenses for the nine months ended February 28, 2019 and 2018 were $434,790 and $557,005, respectively. Operating expenses as a percentage of revenues for the nine months ended February 28, 2019 and 2018 were 66% and 119% respectively. Operating expenses for the nine months ended February 28, 2019 decreased by $122,215 or 22% compared to the comparable period in 2018.On a GAAP basis, our net loss was $154,910. This compares to a net loss of $340,937 in the first nine months of 2018.

About Reviv3
Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.

Forward-Looking Statements

This press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as “anticipates,” “expects,” “intends,” “plans,” “confident that” and “believes,” among others, generally identify forward-looking statements.These forward-looking statements are based on currently available information, and management’s belief, projections, and current expectations subject to a number of significant risks and uncertainties. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3’s ability to grow net sales and adjusted EBITDA as anticipated; (ii) our ability to fund our operating expenses (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3’s ability to compete effectively with other hair and skin care companies (v) the concentration of Reviv3’s customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which Reviv3 operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase Reviv3’s product costs and other costs of doing business, and reduce Reviv3’s earnings. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

Christopher Go
888-638-8883
[e-mail]

[Quintessence]

10-Q out. Haven't had a chance to read it thoroughly yet, but looks like sales are up compared to last year.

[StaleyCornell]

Those who hold aren't selling. Looks like the ask is the only way to get shares

[Quintessence]

Large bids at .70 and under. If they could just move just move up some...

[Quintessence]

I like the share structure. Nice low float.

Outstanding Shares 41,265,047 11/30/2018
Restricted 41,121,833 11/30/2018
Unrestricted 143,214 11/30/2018
Held at DTC 143,214 11/30/2018
Float 4,251,365 10/09/2018

https://www.otcmarkets.com/stock/RVIV/security

[Quintessence]

Nope, I'm in. RVIV is off to a slow start, but I think we could see some good action down the road...

[StaleyCornell]

Noticed that also. Damn I thought I was a loner here. Lol

[Quintessence]

Yes, and getting some pretty good reviews.

https://www.amazon.com/Reviv3-Procare-Day-Trial-Kit/dp/B00VXRJKC8

[StaleyCornell]

Products selling on Amazon

[StaleyCornell]

started trading on December 3

[StaleyCornell]

from .25 to 1.10

[StaleyCornell]

https://www.otcmarkets.com/stock/rviv/profile